Abstract
Introduction
While the United States Preventative Services Task Force recommends osteoporosis screening for women 65 years and older, there is no definitive recommendation for routine osteoporosis screening in men. The purpose of this study was to determine the age at which the odds of fragility fractures (FFx) increase in men to help guide future policy discussions evaluating an optimal screening strategy in this population.
Methods
Men older than 49 years were identified in the PearlDiver Patient Records Database. Patients were excluded if they had a prior fragility fracture, if they were at high risk for osteoporosis due to comorbidities, or if they carried a diagnosis of and/or were on treatment for osteoporosis. The prevalence of FFx was trended for each age group. A stratum-specific likelihood ratio (SSLR) analysis was conducted to identify data-driven strata that maximize the incremental FFx risk by age for men. Logistic regression analyses controlling for potential confounders were conducted to test these identified strata.
Results
The incidence of FFx started to increase after the age of 64 years for men. Further, the identified data-driven age strata associated with a significant and incremental difference in fragility fractures were the following: 50–64, 65–69, 70–72, 73–75, 76–78, 79–80, and 81+. When compared to the youngest age stratum (50–64 years), multivariable regression showed the risk of fragility fracture incrementally increased starting in those aged 70–72 (RR, 1.31; 95% CI. 1.21–1.46; p < 0.001) with the highest risk in those aged 81+ (RR, 5.35; 95% CI, 5.10–5.62; p < 0.001).
Conclusion
In men without a pre-existing history of osteoporosis, the risk of fragility fractures starts to increase after the age of 70. Further work building upon these data may help to identify a specific age at which routine bone health screening in males can help to minimize fractures and their associated morbidity and mortality.
Similar content being viewed by others
Data availability
The database utilized for this study does not permit individual patient information to users but provides aggregate information. Thus, the authors are unable to provide individual patient information from the database.
References
Han RJ, Sing DC, Feeley BT et al (2016) Proximal humerus fragility fractures: recent trends in nonoperative and operative treatment in the Medicare population. J Shoulder Elbow Surg 25:256–261. https://doi.org/10.1016/j.jse.2015.07.015
Friedman SM, Mendelson DA (2014) Epidemiology of fragility fractures. Clin Geriatr Med 30:175–181. https://doi.org/10.1016/j.cger.2014.01.001
Cohn MR, Gianakos AL, Grueter K et al (2018) Update on the comprehensive approach to fragility fractures. J Orthop Trauma 32:480–490. https://doi.org/10.1097/BOT.0000000000001244
Nayak S, Greenspan SL (2016) Cost-effectiveness of osteoporosis screening strategies for men. J Bone Miner Res 31:1189–1199. https://doi.org/10.1002/jbmr.2784
Williams SA, Daigle SG, Weiss R et al (2021) Economic burden of osteoporosis-related fractures in the US Medicare Population. Ann Pharmacother 55:821–829. https://doi.org/10.1177/1060028020970518
Valentin G, Friis K, Nielsen CP et al (2021) Fragility fractures and health-related quality of life: does socio-economic status widen the gap? A population-based study. Osteoporos Int 32:63–73. https://doi.org/10.1007/s00198-020-05540-8
US Preventive Services Task Force, Curry SJ, Krist AH et al (2018) Screening for osteoporosis to prevent fractures: US Preventive Services Task Force Recommendation Statement. JAMA 319:2521–2531. https://doi.org/10.1001/jama.2018.7498
Mears SC, Kates SL (2015) A guide to improving the care of patients with fragility fractures, Edition 2. Geriatr Orthop Surg Rehabil 6:58–120. https://doi.org/10.1177/2151458515572697
Armas LAG, Recker RR (2012) Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol Metab Clin North Am 41:475–486. https://doi.org/10.1016/j.ecl.2012.04.006
Burge R, Dawson-Hughes B, Solomon DH et al (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465–475. https://doi.org/10.1359/jbmr.061113
Reginster J-Y, Burlet N (2006) Osteoporosis: a still increasing prevalence. Bone 38:S4–S9. https://doi.org/10.1016/j.bone.2005.11.024
Khosla S, Shane E (2016) A crisis in the treatment of osteoporosis. J Bone Miner Res 31:1485–1487. https://doi.org/10.1002/jbmr.2888
Alswat KA (2017) Gender disparities in osteoporosis. J Clin Med Res 9:382–387. https://doi.org/10.14740/jocmr2970w
Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381. https://doi.org/10.1007/s00198-014-2794-2
Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB (2009) Incidence and mortality of hip fractures in the United States. JAMA 302:1573–1579. https://doi.org/10.1001/jama.2009.1462
Viswanathan VK, Shetty AP, Rai N et al (2023) What is the role of CT-based Hounsfield unit assessment in the evaluation of bone mineral density in patients undergoing 1- or 2-level lumbar spinal fusion for degenerative spinal pathologies?: a prospective study. Spine J. https://doi.org/10.1016/j.spinee.2023.05.015
Haentjens P, Magaziner J, Colón-Emeric CS et al (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152:380–390. https://doi.org/10.7326/0003-4819-152-6-201003160-00008
Bliuc D, Nguyen ND, Milch VE et al (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521. https://doi.org/10.1001/jama.2009.50
Trombetti A, Herrmann F, Hoffmeyer P et al (2002) Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 13:731–737. https://doi.org/10.1007/s001980200100
Rabenda V, Vanoverloop J, Fabri V et al (2008) Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg Am 90:2142–2148. https://doi.org/10.2106/JBJS.G.00864
Bawa HS, Weick J, Dirschl DR (2015) Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample. J Bone Joint Surg Am 97:1555–1562. https://doi.org/10.2106/JBJS.N.01275
García-Sempere A, Hurtado I, Sanfélix-Genovés J et al (2017) Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study. Sci Rep 7:11784. https://doi.org/10.1038/s41598-017-10899-6
Morin S, Lix LM, Azimaee M et al (2011) Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int 22:2439–2448. https://doi.org/10.1007/s00198-010-1480-2
Bouxsein ML, Melton LJ, Riggs BL et al (2006) Age- and sex-specific differences in the factor of risk for vertebral fracture: a population-based study using QCT. J Bone Miner Res 21:1475–1482. https://doi.org/10.1359/jbmr.060606
Ahmed LA, Center JR, Bjørnerem A et al (2013) Progressively increasing fracture risk with advancing age after initial incident fragility fracture: the Tromsø study. J Bone Miner Res 28:2214–2221. https://doi.org/10.1002/jbmr.1952
Papaioannou A, Kennedy CC, Ioannidis G et al (2008) The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int 19:581–587. https://doi.org/10.1007/s00198-007-0483-0
Bliuc D, Alarkawi D, Nguyen TV et al (2015) Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 30:637–646. https://doi.org/10.1002/jbmr.2393
Bennett MJ, Center JR, Perry L (2023) Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study. Osteoporos Int 34:1249–1262. https://doi.org/10.1007/s00198-023-06748-0
Manolagas SC (2018) The quest for osteoporosis mechanisms and rational therapies: how far we’ve come, how much further we need to go. J Bone Miner Res 33:371–385. https://doi.org/10.1002/jbmr.3400
Lorentzon M, Cummings SR (2015) Osteoporosis: the evolution of a diagnosis. J Intern Med 277:650–661. https://doi.org/10.1111/joim.12369
Curtis EM, Moon RJ, Harvey NC, Cooper C (2017) The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. Bone 104:29–38. https://doi.org/10.1016/j.bone.2017.01.024
Agarwal AR, Cohen JS, Jorgensen A et al (2023) Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019. Osteoporos Int 34:379–385. https://doi.org/10.1007/s00198-022-06622-5
Kreulen RT, Agarwal AR, Nayar SK et al (2022) SLAP repair and bicep tenodesis: a comparison of utilization and revision rates for SLAP tears. JSES Int 7:290–295. https://doi.org/10.1016/j.jseint.2022.11.001
Agarwal AR, Ahmed AF, Stadecker M et al (2023) Trends in venous thromboembolism after shoulder arthroplasty in the United States: analysis following the 2009 American Academy of Orthopaedic Surgeons Clinical Practical Guidelines. J Am Acad Orthop Surg 31:364–372. https://doi.org/10.5435/JAAOS-D-22-00825
Ross BJ, Ross AJ, Lee OC et al (2022) Osteoporosis management and secondary fragility fracture rates in patients with multiple sclerosis: a matched cohort study. Osteoporos Int 33:1999–2010. https://doi.org/10.1007/s00198-022-06451-6
Peirce JC, Cornell RG (1993) Integrating stratum-specific likelihood ratios with the analysis of ROC curves. Med Decis Making 13:141–151. https://doi.org/10.1177/0272989X9301300208
Gu A, Fassihi SC, Wessel LE et al (2021) Comparison of revision risk based on timing of knee arthroscopy prior to total knee arthroplasty. J Bone Joint Surg Am 103:660–667. https://doi.org/10.2106/JBJS.20.00218
Harris AB, Wang KY, Reddy R et al (2022) A novel method for stratification of major complication risk using body mass index thresholds for patients undergoing total hip arthroplasty: a national cohort of 224,413 patients. J Arthroplasty 37:2049–2052. https://doi.org/10.1016/j.arth.2022.04.030
Navarro SM, Haeberle HS, Mont MA et al (2019) Stratum-specific likelihood ratio analysis: an evidence-based and pragmatic approach to meaningful thresholds in lower extremity Arthroplasty. Surg Technol Int 34:415–420
Haeberle HS, Navarro SM, Frankel WC et al (2018) Evidence-based thresholds for the volume and cost relationship in total hip arthroplasty: outcomes and economies of scale. J Arthroplasty 33:2398–2404. https://doi.org/10.1016/j.arth.2018.02.093
Ramkumar PN, Navarro SM, Haeberle HS et al (2017) Evidence-based thresholds for the volume-value relationship in shoulder arthroplasty: outcomes and economies of scale. J Shoulder Elbow Surg 26:1399–1406. https://doi.org/10.1016/j.jse.2017.05.019
Pisani P, Renna MD, Conversano F et al (2016) Major osteoporotic fragility fractures: risk factor updates and societal impact. World J Orthop 7:171–181. https://doi.org/10.5312/wjo.v7.i3.171
Watts NB, Adler RA, Bilezikian JP et al (2012) Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97:1802–1822. https://doi.org/10.1210/jc.2011-3045
Drake MT, Murad MH, Mauck KF et al (2012) Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 97:1861–1870. https://doi.org/10.1210/jc.2011-3058
Schousboe JT, Taylor BC, Fink HA et al (2007) Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA 298:629–637. https://doi.org/10.1001/jama.298.6.629
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Agarwal, Tarawneh, Gu, Jordan, and Moseley have no conflicts of interests to disclose. Debritz is a paid consultant for Avenos and has stock/stock options with Johnson & Johnson. Golladay is a board/committee member of AAHKS and Viginia Orthopaedic Society. Golladay is an editorial/goverming board member of JOA and Arthroplasty Today. Golladay receives publishing royalties and financial/material support from Arthroplasty Today. Golladay receives IP royalties from Stryker. Thakkar is a board/committee member of AAHKS. Thakkar is an editorial/goverming board member of JOA and Arthroplasty Today. Thakkar is an unpaid consultant for KCI and OrthAlign. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Summary
Utilizing a data-driven analysis, this study found that the risk of fragility fractures in men starts to increase following the age of 70. To reduce the risk of these complications, physicians should ensure prompt diagnosis and treatment in men before the age of 70 to prevent these sentinel events.
Appendix
Appendix
Category | ICD or CPT billing code |
---|---|
routine primary care/family physician visit | CPT-99386, CPT-99387, CPT-99397, CPT-Z0000, CPT-Z0001 |
Fragility fractures (Fragility when excluding traumatic injury) | |
Spine fracture | ICD-9-D-80500, ICD-9-D-80501, ICD-9-D-80502, ICD-9-D-80503, ICD-9-D-80504, ICD-9-D-80505, ICD9-D-80506, ICD-9-D-80507, ICD-9-D-8052, ICD-9-D-8054, ICD-9-D-8058, ICD-9-D-8060, ICD-9-D80600:ICD-9-D-80609, ICD-9-D-80620:ICD-9-D-80629, ICD-9-D-8064, ICD-9-D-8068, ICD-9-D-73313, ICD-10-D-S129XXA, ICD-10-D-S12000A, ICD-10-D-S12001A, ICD-10-D-S12100A, ICD-10-DS12101A, ICD-10-D-S12200A, ICD-10-D-S12201A, ICD-10-D-S12300A, ICD-10-D-S12301A, ICD10-D-S12400A, ICD-10-D-S12401A, ICD-10-D-S12500A, ICD-10-D-S12501A, ICD-10-D-S12600A, ICD-10-D-S12601A, ICD-10-D-S22009A, ICD-10-D-S32009A, ICD-10-D-S3210XA, ICD-10-DS322XXA, ICD-10-D-S14101A, ICD-10-D-S14102A, ICD-10-D-S14103A, ICD-10-D-S14104A, ICD10-D-S14111A, ICD-10-D-S14112A, ICD-10-D-S14113A, ICD-10-D-S14114A, ICD-10-D-S14121A, ICD-10-D-S14122A, ICD-10-D-S14123A, ICD-10-D-S14124A, ICD-10-D-S14131A, ICD-10-DS14132A, ICD-10-D-S14133A, ICD-10-D-S14134A, ICD-10-D-S14151A, ICD-10-D-S14152A, ICD10-D-S14153A, ICD-10-D-S14154A, ICD-10-D-S14105A, ICD-10-D-S14106A, ICD-10-D-S14107A, ICD-10-D-S14115A, ICD-10-D-S14116A, ICD-10-D-S14117A, ICD-10-D-S14125A, ICD-10-DS14126A, ICD-10-D-S14127A, ICD-10-D-S14135A, ICD-10-D-S14136A, ICD-10-D-S14137A, ICD-10- D-S14155A, ICD-10-D-S14156A, ICD-10-D-S14157A, ICD-10-D-S24101A, ICD-10-D-S24102A, ICD10-D-S24111A, ICD-10-D-S24112A, ICD-10-D-S24131A, ICD-10-D-S24132A, ICD-10-D-S24151A, ICD-10-D-S24152A, ICD-10-D-S24103A, ICD-10-D-S24104A, ICD-10-D-S24113A, ICD-10-DS24114A, ICD-10-D-S24133A, ICD-10-D-S24134A, ICD-10-D-S24153A, ICD-10-D-S24154A, ICD-10- D-S34109A, ICD-10-D-S34119A, ICD-10-D-S34129A, ICD-10-D-S32009A, ICD-10-D-S34101A, ICD10-D-S34111A, ICD-10-D-S34121A, ICD-10-D-S32019A, ICD-10-D-S34102A, ICD-10-D-S34112A, ICD-10-D-S34122A, ICD-10-D-S32029A, ICD-10-D-S34103A, ICD-10-D-S34113A, ICD-10-DS34123A, ICD-10-D-S32039A, ICD-10-D-S34104A, ICD-10-D-S34114A, ICD-10-D-S34124A, ICD-10- D-S32049A, ICD-10-D-S34105A, ICD-10-D-S34115A, ICD-10-D-S34125A, ICD-10-D-S32059A, ICD10-D-S14109A, ICD-10-D-S24109A, ICD-10-D-S34109A, ICD-10-D-S34139A, ICD-10-D-M4850XA, ICD-10-D-M8008XA, ICD-10-D-M8448XA, ICD-10-D-M8468XA, ICD-9-D-73313, ICD-9-D-73315, ICD-10-D-M8008XA, ICD-10-D-M8088XA |
Hip fracture | ICD-9-D-82000:ICD-9-D-82009, ICD-9-D-82020:ICD-9-D-82022, ICD-9-D-8208, ICD-9-D-73314, ICD10-D-S72001A, ICD-10-D-S72002A, ICD-10-D-S72009A, ICD-10-D-S72011A, ICD-10-D-S72012A, ICD-10-D-S72019A, ICD-10-D-S72021A, ICD-10-D-S72022A, ICD-10-D-S72023A, ICD-10-DS72031A, ICD-10-D-S72032A, ICD-10-D-S72033A, ICD-10-D-S72041A, ICD-10-D-S72042A, ICD-10- D-S72043A, ICD-10-D-S72091A, ICD-10-D-S72092A, ICD-10-D-S72099A, ICD-10-D-S72101A, ICD10-D-S72102A, ICD-10-D-S72109A, ICD-10-D-S72141A, ICD-10-D-S72142A, ICD-10-D-S72143A, ICD-10-D-S72231A, ICD-10-D-S72232A, ICD-10-D-S7223XA, ICD-10-D-M84451A, ICD-10-DM84452A, ICD-10-D-M84453A, ICD-10-D-M84459A, ICD-9-D-73314, ICD-10-D-M80051A, ICD-10- D-M80052A, ICD-10-D-M80059A, ICD-10-D-M80851A, ICD-10-D-M80852A, ICD-10-D-M80859A |
Pelvic fracture | ICD-9-D-8080, ICD-9-D-8082, ICD-9-D-80841, ICD-9-D-80842, ICD-9-D-80849, ICD-9-D-8088, ICD10-D-S32401A, ICD-10-D-S32402A, ICD-10-D-S32409A, ICD-10-D-S32501A, ICD-10-D-S32502A, ICD-10-D-S32501A, ICD-10-D-S32502A, ICD-10-D-S32509A, ICD-10-D-S32301A, ICD-10-DS32302A, ICD-10-D-S32309A, ICD-10-D-S32601A, ICD-10-D-S32602A, ICD-10-D-S32609A, ICD10-D-S32810A, ICD-10-D-S32811A, ICD-10-D-S3282XA, ICD-10-D-S3289XA, ICD-10-D-S329XXA, ICD-10-D-M84454A |
Wrist fracture | ICD-9-D-81340:ICD-9-D-81347, ICD-9-D-73312, ICD-10-D-S5290XA, ICD-10-D-S52531A, ICD-10-DS52532A, ICD-10-D-S52539A, ICD-10-D-S52541A, ICD-10-D-S52542A, ICD-10-D-S52549A, ICD10-D-S52501A, ICD-10-D-S52502A, ICD-10-D-S52509A, ICD-10-D-S52601A, ICD-10-D-S52602A, ICD-10-D-S52609A, ICD-10-D-S52111A, ICD-10-D-S52112A, ICD-10-D-S52119A, ICD-10-DS52521A, ICD-10-D-S52522A, ICD-10-D-S52529A, ICD-10-D-S52011A, ICD-10-D-S52012A, ICD-10- D-S52019A, ICD-10-D-S52621A, ICD-10-D-S52622A, ICD-10-D-S52629A, ICD-10-D-S52011A, ICD10-D-S52012A, ICD-10-D-S52019A, ICD-10-D-S52621A, ICD-10-D-A52622A, ICD-10-D-S52629A, ICD-10-D-M84431A, ICD-10-D-M84432A, ICD-10-D-M84439A, ICD-9-D-73312, ICD-10-D-M80031A, ICD-10-D-M80032A, ICD-10-D-M80039A, ICD-10-D-M80831A, ICD-10-D-M80832A, ICD-10-DM80839A |
Humerus fracture | ICD-9-D-81200:ICD-9-D-81209, ICD-9-D-81220, ICD-9-D-81221, ICD-9-D-81240:ICD-9-D-81249, ICD9-D-73311, ICD-10-D-S42201A, ICD-10-D-S42202A, ICD-10-D-S42209A, ICD-10-D-S42211A, ICD10-D-S42212A, ICD-10-D-S42213A, ICD-10-D-S42214A, ICD-10-D-S42215A, ICD-10-D-S42216A, ICD-10-D-S42291A, ICD-10-D-S42292A, ICD-10-D-S42293A, ICD-10-D-S42294A, ICD-10-DS42295A, ICD-10-D-S42296A, ICD-10-D-S42251A, ICD-10-D-S42252A, ICD-10-D-S42253A, ICD10-D-S42254A, ICD-10-D-S42255A, ICD-10-D-S42256A, ICD-10-D-S42291A, ICD-10-D-S42292A, ICD-10-D-S42293A, ICD-10-D-S42294A, ICD-10-D-S42295A, ICD-10-D-S42296A, ICD-10-DS42301A, ICD-10-D-S42302A, ICD-10-D-S42309A, ICD-10-D-S42391A, ICD-10-D-S42392A, ICD-10- D-S42399A, ICD-10-D-S42401A, ICD-10-D-S42402A, ICD-10-D-S42409A, ICD-10-D-S42411A, ICD10-D-S42412A, ICD-10-D-S42413A, ICD-10-D-S42414A, ICD-10-D-S42415,A ICD-10-D-S42416A, ICD-10-D-S42431A, ICD-10-D-S42432A, ICD-10-D-S42433A, ICD-10-D-S42434A, ICD-10-DS42435A, ICD-10-D-S42436A, ICD-10-D-S42451A, ICD-10-D-S42452A, ICD-10-D-S42453A, ICD-10- D-S42454A, ICD-10-D-S42455A, ICD-10-D-S42456A, ICD-10-D-S42441A, ICD-10-D-S42442A, ICD10-D-S42443A, ICD-10-D-S42444A, ICD-10-D-S42445A, ICD-10-D-S42446A, ICD-10-D-S42461A, ICD-10-D-S42462A, ICD-10-D-S42463A, ICD-10-D-S42464A, ICD-10-D-S42465A, ICD-10-DS42466A, ICD-10-D-S42471A, ICD-10-D-S42472A, ICD-10-D-S42473A, ICD-10-D-S42474A, ICD-10- D-S42475A, ICD-10-D-S42476A, ICD-10-D-S42491A, ICD-10-D-S42492A, ICD-10-D-S42493A, ICD10-D-S42494A, ICD-10-D-S42495A, ICD-10-D-S42496A, ICD-10-D-M84421A, ICD-10-D-M84422A, ICD-10-D-M84429A, ICD-9-D-73311, ICD-10-D-M80011A, ICD-10-D-M80012A, ICD-10-D-M80019A, ICD-10-D-M80021A, ICD-10-D-M80022A, ICD-10-D-M80029A, ICD-10-D-M80811A, ICD-10-DM80812A, ICD-10-D-M80819A, ICD-10-D-M80821A, ICD-10-D-M80822A, ICD-10-D-M80829A |
Other fracture | ICD-9-D-73310, ICD-9-D-73316, ICD-9-D-73319, ICD-10-D-M8000XA, ICD-10-D-M80041A, ICD-10- D-M80042A, ICD-10-D-M80049A, ICD-10-D-M80061A, ICD-10-D-M80062A, ICD-10-D-M80069A, ICD-10-D-M80071A, ICD-10-D-M80072A, ICD-10-D-M80079A, ICD-10-D-M8080XA, ICD-10-DM80841A, ICD-10-D-M80842A, ICD-10-D-M80849A, ICD-10-D-M80861A, ICD-10-D-M80862A, ICD10-D-M80869A, ICD-10-D-M80871A, ICD-10-D-M80872A, ICD-10-D-M80879A |
Traumatic injury | ICD-9-D-E8120, ICD-9-D-E8121, ICD-9-D-E8199, ICD-9-D-E8190, ICD-9-D-E8160, ICD-9-DE8129, ICD-9-D-E8191, ICD-9-D-E8147, ICD-9-D-E8150, ICD-9-D-E8130, ICD-9-D-E8210, ICD-9-D-E8161, ICD-9-D-E8192, ICD-9-D-E8162, ICD-9-D-E8131, ICD-9-D-E8122, ICD-9-DE8219, ICD-9-D-E8151, ICD-9-D-E8136, ICD-9-D-E8181, ICD-9-D-E8189, ICD-9-D-E8197, ICD-9-D-E8259, ICD-9-D-E8212, ICD-9-D-E8180, ICD-9-D-E8250, ICD-9-D-E8171, ICD-9-DE8182, ICD-9-D-E8179, ICD-9-D-E8249, ICD-9-D-E8230, ICD-9-D-E8211, ICD-9-D-E8241, ICD-9-D-E8139, ICD-9-D-E8252, ICD-9-D-E8127, ICD-9-D-E8149, ICD-9-D-E8128, ICD-9-DE8152, ICD-9-D-E8198, ICD-9-D-E8251, ICD-9-D-E8169, ICD-9-D-E9885, ICD-9-D-E8187, ICD-9-D-E8159, ICD-9-D-E8257, ICD-9-D-E8146, ICD-9-D-E8132, ICD-9-D-E8123, ICD-9-DE8110, ICD-9-D-E8240, ICD-9-D-E8170, ICD-9-D-E8126, ICD-9-D-E8188, ICD-9-D-E8196, ICD-9-D-E8200, ICD-9-D-E8193, ICD-9-D-E8258, ICD-9-D-E8218, ICD-9-D-E8231, ICD-9-DE8220, ICD-9-D-E8158, ICD-9-D-E8163, ICD-9-D-E8227, ICD-9-D-E8111, ICD-9-D-E8209, ICD-9-D-E8140, ICD-9-D-E8248, ICD-9-D-E8217, ICD-9-D-E8138, ICD-9-D-E8183, ICD-9-DE8232, ICD-9-D-E8682, ICD-9-D-E8100, ICD-9-D-E8178, ICD-9-D-E8137, ICD-9-D-E8148, ICD-9-D-E8239, ICD-9-D-E8221, ICD-9-D-E8141, ICD-9-D-E8242, ICD-9-D-E8186, ICD-9-DE8229, ICD-9-D-E8237, ICD-9-D-E8172, ICD-9-D-E8119, ICD-9-D-E8133, ICD-9-D-E8216, ICD-9-D-E8124, ICD-9-D-E8177, ICD-9-D-E8213, ICD-9-D-E8168, ICD-9-D-E8101, ICD-9-DE8208, ICD-9-D-E8153, ICD-9-D-E8157, ICD-9-D-E8194, ICD-9-D-E8222, ICD-9-D-E8134, ICD-9-D-E8167, ICD-9-D-E8226, ICD-9-D-E8142, ICD-9-D-E8201, ICD-9-D-E8166, ICD-9-DE8109, ICD-9-D-E8154, ICD-9-D-E8174, ICD-9-D-E8256, ICD-9-D-E8156, ICD-9-D-E8238, ICD-9-D-E8253, ICD-9-D-E8143, ICD-9-D-E8228, ICD-9-D-E8195, ICD-9-D-E9820, ICD-9-DE8173, ICD-9-D-E8184, ICD-9-D-E8164, ICD-9-D-E8202, ICD-9-D-E8243, ICD-9-D-E8247, ICD-9-D-E8112, ICD-9-D-E8203, ICD-9-D-E8236, ICD-9-D-E8102, ICD-9-D-E8107, ICD-9-DE8103, ICD-9-D-E8104, ICD-9-D-E8106, ICD-9-D-E8108, ICD-9-D-E8113, ICD-9-D-E8114, ICD-9-D-E8115, ICD-9-D-E8118, ICD-9-D-E8125, ICD-9-D-E8135, ICD-9-D-E8144, ICD-9-DE8145, ICD-9-D-E8155, ICD-9-D-E8175, ICD-9-D-E8176, ICD-9-D-E8185, ICD-9-D-E8204, ICD-9-D-E8205, ICD-9-D-E8206, ICD-9-D-E8207, ICD-9-D-E8214, ICD-9-D-E8215, ICD-9-DE8223, ICD-9-D-E8224, ICD-9-D-E8225, ICD-9-D-E8233, ICD-9-D-E8234, ICD-9-D-E8244, ICD-9-D-E8245, ICD-9-D-E8246, ICD-9-D-E8254, ICD-9-D-E8255, ICD-9-D-E9871, ICD-9-DE8849, ICD-9-D-E8810, ICD-9-D-E8801, ICD-9-D-E882, ICD-9-D-E8850, ICD-9-D-E8839, ICD-9-D-E8853, ICD-9-D-E8854, ICD-9-D-E9879, ICD-9-D-E8800, ICD-9-D-E8811, ICD-9-DE8342, ICD-9-D-E8841, ICD-9-D-E8351, ICD-9-D-E8832, ICD-9-D-E8359, ICD-9-D-E8343, ICD-9-D-E8353, ICD-9-D-E8349, ICD-9-D-E8354, ICD-9-D-E8439, ICD-9-D-E8831, ICD-9-DE8339, ICD-9-D-E8041, ICD-9-D-E8341, ICD-9-D-E8348, ICD-9-D-E8260, ICD-9-D-E8261, ICD-9-D-E8262, ICD-9-D-E8263, ICD-9-D-E8264, ICD-9-D-E8268, ICD-9-D-E8269, ICD-9-DE8290, ICD-9-D-E8294, ICD-9-D-E8298, ICD-9-D-E8299, ICD-10-D-V0200XA, ICD-10-D-V0209XA, ICD-10-D-V0210XA, ICD-10-D-V0212XA, ICD-10-D-V0219XA, ICD-10-D-V0290XA, ICD-10-D-V0299XA, ICD-10-D-V0600XA, ICD-10-D-V0609XA, ICD-10-D-V0610XA, ICD-10-D-V0612XA, ICD-10-D-V0619XA, ICD-10-D-V0690XA, ICD-10-D-V0692XA, ICD-10-D-V0699XA, ICD-10-D-V0900XA, ICD-10-D-V0909XA, ICD-10-D-V0920XA, ICD-10-D-V0929XA, ICD-10-D-V120XXA, ICD-10-D-V121XXA, ICD-10-D-V122XXA, ICD-10-D-V123XXA, ICD-10-D-V124XXA, ICD-10-D-V125XXA, ICD-10-D-V129XXA, ICD-10-D-V160XXA, ICD-10-D-V162XXA, ICD-10-D-V163XXA, ICD-10-D-V164XXA, ICD-10-D-V169XXA, ICD-10-D-V1900XA, ICD-10-D-V1909XA, ICD-10-D-V1910XA, ICD-10-D-V1919XA, ICD-10-D-V1920XA, ICD-10-D-V1929XA, ICD-10-D-V1940XA, ICD-10-D-V1949XA, ICD-10-D-V1950XA, ICD-10-D-V1959XA, ICD-10-D-V1960XA, ICD-10-D-V1969XA, ICD-10-D-V220XXA, ICD-10-D-V221XXA, ICD-10-D-V222XXA, ICD-10-D-V223XXA, ICD-10-D-V224XXA, ICD-10-D-V225XXA, ICD-10-D-V229XXA, ICD-10-D-V240XXA, ICD-10-D-V241XXA, ICD-10-D-V244XXA, ICD-10-D-V245XXA, ICD-10-D-V249XXA, ICD-10-D-V250XXA, ICD-10-D-V254XXA, ICD-10-D-V255XXA, ICD-10-D-V259XXA, ICD-10-D-V260XXA, ICD-10-D-V261XXA, ICD-10-D-V262XXA, ICD-10-D-V263XXA, ICD-10-D-V264XXA, ICD-10-D-V265XXA, ICD-10-D-V269XXA, ICD-10-D-V2900XA, ICD-10-D-V2909XA, ICD-10-D-V2910XA, ICD-10-D-V2919XA, ICD-10-D-V2920XA, ICD-10-D-V2929XA, ICD-10-D-V2940XA, ICD-10-D-V2949XA, ICD-10-D-V2950XA, ICD-10-D-V2959XA, ICD-10-D-V2960XA, ICD-10-D-V2969XA, ICD-10-D-V2981XA, ICD-10-D-V300XXA, ICD-10-D-V302XXA, ICD-10-D-V306XXA, ICD-10-D-V307XXA, ICD-10-D-V309XXA, ICD-10-D-V310XXA, ICD-10-D-V315XXA, ICD-10-D-V320XXA, ICD-10-D-V321XXA, ICD-10-D-V322XXA, ICD-10-D-V325XXA, ICD-10-D-V326XXA, ICD-10-D-V327XXA, ICD-10-D-V329XXA, ICD-10-D-V330XXA, ICD-10-D-V331XXA, ICD-10-D-V335XXA, ICD-10-D-V336XXA, ICD-10-D-V339XXA, ICD-10-D-V342XXA, ICD-10-D-V343XXA, ICD-10-D-V346XXA, ICD-10-D-V349XXA, ICD-10-D-V353XXA, ICD-10-D-V356XXA, ICD-10-D-V360XXA, ICD-10-D-V361XXA, ICD-10-D-V363XXA, ICD-10-D-V365XXA, ICD-10-D-V366XXA, ICD-10-D-V369XXA, ICD-10-D-V370XXA, ICD-10-D-V371XXA, ICD-10-D-V373XXA, ICD-10-D-V375XXA, ICD-10-D-V376XXA, ICD-10-D-V377XXA, ICD-10-D-V379XXA, ICD-10-D-V380XXA, ICD-10-D-V381XXA, ICD-10-D-V383XXA, ICD-10-D-V384XXA, ICD-10-D-V385XXA, ICD-10-D-V386XXA, ICD-10-D-V389XXA, ICD-10-D-V3900XA, ICD-10-D-V3919XA, ICD-10-D-V3920XA, ICD-10-D-V393XXA, ICD-10-D-V3940XA, ICD-10-D-V3949XA, ICD-10-D-V3959XA, ICD-10-D-V3960XA, ICD-10-D-V3969XA, ICD-10-D-V3981XA, ICD-10-D-V3989XA, ICD-10-D-V399XXA, ICD-10-D-V420XXA, ICD-10-D-V421XXA, ICD-10-D-V422XXA, ICD-10-D-V424XXA, ICD-10-D-V425XXA, ICD-10-D-V426XXA, ICD-10-D-V427XXA, ICD-10-D-V429XXA, ICD-10-D-V460XXA, ICD-10-D-V461XXA, ICD-10-D-V462XXA, ICD-10-D-V463XXA, ICD-10-D-V464XXA, ICD-10-D-V465XXA, ICD-10-D-V466XXA, ICD-10-D-V467XXA, ICD-10-D-V469XXA, ICD-10-D-V4900XA, ICD-10-D-V4909XA, ICD-10-D-V4910XA, ICD-10-D-V4919XA, ICD-10-D-V4920XA, ICD-10-D-V4929XA, ICD-10-D-V4940XA, ICD-10-D-V4949XA, ICD-10-D-V4950XA, ICD-10-D-V4959XA, ICD-10-D-V4960XA, ICD-10-D-V4969XA, ICD-10-D-V525XXA, ICD-10-D-V526XXA, ICD-10-D-V529XXA, ICD-10-D-V561XXA, ICD-10-D-V564XXA, ICD-10-D-V565XXA, ICD-10-D-V566XXA, ICD-10-D-V567XXA, ICD-10-D-V569XXA, ICD-10-D-V5900XA, ICD-10-D-V5909XA, ICD-10-D-V5910XA, ICD-10-D-V5919XA, ICD-10-D-V5920XA, ICD-10-D-V5929XA, ICD-10-D-V5940XA, ICD-10-D-V5949XA, ICD-10-D-V5950XA, ICD-10-D-V5959XA, ICD-10-D-V5960XA, ICD-10-D-V5969XA, ICD-10-D-V621XXA, ICD-10-D-V624XXA, ICD-10-D-V629XXA, ICD-10-D-V665XXA, ICD-10-D-V666XXA, ICD-10-D-V667XXA, ICD-10-D-V6900XA, ICD-10-D-V6909XA, ICD-10-D-V6910XA, ICD-10-D-V6920XA, ICD-10-D-V6940XA, ICD-10-D-V6949XA, ICD-10-D-V6950XA, ICD-10-D-V6959XA, ICD-10-D-V6960XA, ICD-10-D-V721XXA, ICD-10-D-V722XXA, ICD-10-D-V723XXA, ICD-10-D-V724XXA, ICD-10-D-V726XXA, ICD-10-D-V760XXA, ICD-10-D-V761XXA, ICD-10-D-V762XXA, ICD-10-D-V763XXA, ICD-10-D-V764XXA, ICD-10-D-V765XXA, ICD-10-D-V766XXA, ICD-10-D-V769XXA, ICD-10-D-V7900XA, ICD-10-D-V7909XA, ICD-10-D-V7910XA, ICD-10-D-V7919XA, ICD-10-D-V7920XA, ICD-10-D-V7940XA, ICD-10-D-V7949XA, ICD-10-D-V7950XA, ICD-10-D-V7959XA, ICD-10-D-V7960XA, ICD-10-D-V7969XA, ICD-10-D-V8051XA, ICD-10-D-V8052XA, ICD-10-D-V80790A, ICD-10-D-V810XXA, ICD-10-D-V811XXA, ICD-10-D-V820XXA, ICD-10-D-V821XXA, ICD-10-D-V8609XA, ICD-10-D-V8619XA, ICD-10-D-V8629XA, ICD-10-D-V8639XA, ICD-10-D-V8649XA, ICD-10-D-V8659XA, ICD-10-D-V8669XA, ICD-10-D-V8679XA, ICD-10-D-V8699XA, ICD-10-D-V871XXA, ICD-10-D-V877XXA, ICD-10-D-V878XXA, ICD-10-D-V879XXA, ICD-10-D-V880XXA, ICD-10-D-V881XXA, ICD-10-D-V887XXA, ICD-10-D-V888XXA, ICD-10-D-V889XXA, ICD-10-D-V890XXA, ICD-10-D-V891XXA, ICD-10-D-V892XXA, ICD-10-D-V893XXA, ICD-10-D-X810XXA, ICD-10-D-X820XXA, ICD-10-D-X822XXA, ICD-10-D-X828XXA, ICD-10-D-Y020XXA, ICD-10-D-Y030XXA, ICD-10-D-Y038XXA, ICD-10-D-Y32XXXA, ICD-10-D-W002XXA, ICD-10-D-W1789XA, ICD-10-D-W1843XA, ICD-10-D-W109XXA, ICD-10-D-W11XXXA, ICD-10-D-W009XXA, ICD-10-D-W1781XA, ICD-10-D-W14XXXA, ICD-10-D-W132XXA, ICD-10-D-V00321A, ICD-10-D-W051XXA, ICD-10-D-W1782XA, ICD-10-D-V00121A, ICD-10-D-W001XXA, ICD-10-D-W138XXA, ICD-10-D-V00311A, ICD-10-D-W100XXA, ICD-10-D-W133XXA, ICD-10-D-W134XXA, ICD-10-D-W139XXA, ICD-10-D-W12XXXA, ICD-10-D-V00181A, ICD-10-D-W130XXA, ICD-10-D-V9339XA, ICD-10-D-W15XXXA, ICD-10-D-V00891A, ICD-10-D-W131XXA, ICD-10-D-W171XXA, ICD-10-D-V815XXA, ICD-10-D-W170XXA, ICD-10-D-W173XXA |
Osteoporosis-related exclusion | |
Osteoporosis | ICD-9-D-73300, ICD-9-D-73301, ICD-9-D-73302, ICD-9-D-73303, ICD-9-D-73309, ICD-10-DM810, ICD-10-D-M818, ICD-10-D-M816 |
Osteoporosis medications | GENERIC_DRUG-ALENDRONATE_SODIUM, GENERIC_DRUG-ALENDRONATE_SODIUM/VITAMIN_D3, GENERIC_DRUG-RISEDRONATE_SOD/CALCIUM_CARB, GENERIC_DRUG-RISEDRONATE_SODIUM, GENERIC_DRUG-IBANDRONATE_SODIUM, GENERIC_DRUG-ZOLEDRONIC_ACID, DRUG-FOSAMAX, DRUG-FOSAMAX_PLUS_D, DRUG-ACTONEL, DRUG-ACTONEL_WITH_CALCIUM, DRUG-RECLAST, DRUG-BONIVA, GENERIC_DRUG-TERIPARATIDE, GENERIC_DRUG-ABALOPARATIDE, DRUG-TYMLOS, DRUG-FORTEO, GENERIC_DRUG-CALCITONIN_SALMON_SYNTHETIC, DRUG-CALCITONIN-SALMON,GENERIC_DRUG-RALOXIFENE_HCL,GENERIC_DRUG-ESTROGENS_CONJ/BAZEDOXIFENE, DRUG-EVISTA, DRUG-DUAVEE, GENERIC_DRUG-DENOSUMAB, DRUG-PROLIAGENERIC_DRUG-ALENDRONATE_SODIUM, GENERIC_DRUG-ALENDRONATE_SODIUM/VITAMIN_D3, GENERIC_DRUG-RISEDRONATE_SOD/CALCIUM_CARB, GENERIC_DRUG-RISEDRONATE_SODIUM, GENERIC_DRUG-IBANDRONATE_SODIUM, GENERIC_DRUG-ZOLEDRONIC_AC/MANNITOL/0.9NACL, GENERIC_DRUG-ZOLEDRONIC_ACID, GENERIC_DRUG-ZOLEDRONIC_ACID/MANNITOL&WATER, GENERIC_DRUG-ZOLEDRONIC_ACID/MANNITOL-WATER, GENERIC_DRUG-RALOXIFENE_HCL, GENERIC_DRUG-DENOSUMAB, GENERIC_DRUG-TERIPARATIDE, GENERIC_DRUG-ABALOPARATIDE, GENERIC_DRUG-CALCITONIN_SALMON_SYNTHETIC |
DEXA screening | CPT-77080, CPT-77081, CPT-77085, CPT-77086 |
Other exclusion | |
Malignancy | ICD-9-D-1960: ICD-9-D-1999, ICD-10-D-C770: ICD-10-D-C809, ICD-9-D-1400: ICD-9-D-1729, ICD-9-D-1740: ICD-9-D-1959, ICD-10-D-C000: ICD-10-D-C269, ICD-10-D-C300: ICD-10-D-C349, ICD-10-D-C370: ICD-10-D-C419, ICD-10-D-C430: ICD-10-D-C439, ICD-10-D-C450: ICD-10-D-C589, ICD-10-D-C600: ICD-10-D-C769, ICD-10-D-C970: ICD-10-D-C979 |
High-risk cohorts | - |
Smoker | ICD-9-D-3051, ICD-9-D-98984, ICD-10-D-F17200, ICD-10-D-F17201, ICD-10-D-F17210, ICD-10-D-F17211, ICD-10-D-F17220, ICD-10-D-F17221, ICD-10-D-F17290, ICD-10-D-F17291 |
Alcohol abuse/dependence | ICD-9-D-2652, ICD-9-D-2911: ICD-9-D-2913, ICD-9-D-2915: ICD-9-D-2919, ICD-9-D-3030, ICD-9-D-3039, ICD-9-D-3050, ICD-9-D-3575, ICD-9-D-4255, ICD-9-D-5353, ICD-9-D-5710: ICD-9-D-5713, ICD-9-D-9800: ICD-9-D-9809, ICD-9-D-V113, ICD-10-D-F10, ICD-10-D-E52, ICD-10-D-G621, ICD-10-D-I426, ICD-10-D-K292, ICD-10-D-K700, ICD-10-D-K703, ICD-10-D-K709, ICD-10-D-T510: ICD-10-D-T519, ICD-10-D-Z502, ICD-10-D-Z714, ICD-10-D-Z721 |
Chronic corticosteroid usage | ICD-10-D-Z7952, ICD-9-D-V5865 |
Metabolic conditions affecting sex hormones and bone mineral density | ICD-9-D-2532, ICD-10-D-E230, ICD-9-D-6961, ICD-10-D-L400, ICD-10-D-L401, ICD-10-D-L404, ICD-10-D-L4050, ICD-10- D-L408, ICD-10-D-L409, ICD-9-D-2552, ICD-10-D-E259, ICD-10-D-E250, ICD-10-D-E258, ICD-9-D-042, ICD-10-D-B20, ICD-9-D-5712, ICD-9-D-5715, ICD-10-D-K7030, ICD-10-D-K7031, ICD-10-D-K717, ICD-10- D-K7460, ICD-10-D-K7469, ICD-9-D-28243, ICD-9-D-28244, ICD-10-D-D560, ICD-10-D-D561, ICD-9-D-75651, ICD-10-D-Q780, ICD-9-D-28241, ICD-9-D-28242, ICD-9-D-28260, ICD-9-D-28263, ICD-9-D-28269, ICD-9-D28264, ICD-9-D-28268, ICD-10-D-D571, ICD-10-D-D57812, ICD-10-D-D57412, ICD-10-DD57212, ICD-10-D-D57411, ICD-10-D-D57811, ICD-10-D-D57211, ICD-10-D-D57419, ICD10-D-D5780, ICD-10-D-D5740, ICD-10-D-D57819, ICD-10-D-D57219, ICD-10-D-D5720, ICD-9-D-7103, ICD-9-D-7104, ICD-9-D-725, ICD-10-D-M3390, ICD-10-D-M3220, ICD-10-DM353, ICD-9-D-4465, ICD-9-D-4464, ICD-9-D-4460, ICD-10-D-M315, ICD-10-D-M316, ICD-10-DM3130, ICD-10-D-M3131, ICD-10-D-M317, ICD-10-D-M300, ICD-10-D-M301, ICD-9-D-340, ICD-10-D-G35, ICD-9-D-24290, ICD-9-D-24200, ICD-10-D-E0590, ICD-10-D-E0500, ICD-10-D-E0520, ICD10-D-E0591, ICD-9-D-5790, ICD-10-D-K900, ICD-9-D-7140, ICD-10-D-M069, CD-9-D-5550, ICD-9-D-5551, ICD-9-D-5552, ICD-9-D-5559, ICD-10-D-K5000, ICD-10-DK50011, ICD-10-D-K50012, ICD-10-D-K50013, ICD-10-D-K50014, ICD-10-D-K50018, ICD10-D-K50019, ICD-10-D-K5010, ICD-10-D-K50111, ICD-10-D-K50112, ICD-10-D-K50113, ICD-10-D-K50114, ICD-10-D-K50118, ICD-10-D-K50119, ICD-10-D-K5080, ICD-10-DK50811, ICD-10-D-K50812, ICD-10-D-K50813, ICD-10-D-K50814, ICD-10-D-K50818, ICD10-D-K50819, ICD-10-D-K5090, ICD-10-D-K50911, ICD-10-D-K50912, ICD-10-D-K50913, ICD-10-D-K50914, ICD-10-D-K50918, ICD-10-D-K50919, ICD-10-D-K5100, ICD-10-DK51011, ICD-10-D-K51012, ICD-10-D-K51013, ICD-10-D-K51014, ICD-10-D-K51018, ICD10-D-K51019, ICD-10-D-K5180, ICD-10-D-K51811, ICD-10-D-K51812, ICD-10-D-K51813, ICD-10-D-K51814, ICD-10-D-K51818, ICD-10-D-K51819, ICD-10-D-K5190, ICD-10-DK51911, ICD-10-D-K51912, ICD-10-D-K51913, ICD-10-D-K51914, ICD-10-D-K51918, ICD10-D-K51919, ICD-9-D-7100, ICD-10-D-M3210, ICD-10-D-M329, ICD-9-D-135, ICD-10-D-D860, ICD-10-D-D861, ICD-10-D-D862, ICD-10-D-D863, ICD-10-DD8687, ICD-9-D-2550, ICD-10-D-E240, ICD-10-D-E242, ICD-10-D-E244, ICD-10-D-E248, ICD-10-DE249, ICD-9-D-25200, ICD-9-D-25201, ICD-9-D-25202, ICD-9-D-25208, ICD-9-D-58881, ICD-10-DE210, ICD-10-D-E211, ICD-10-D-E212, ICD-10-D-E213, ICD-10-D-N2581, ICD-9-D-7310, ICD-9-D-7311, ICD-10-D-M880, ICD-10-D-M881, ICD-10-D-M88811, ICD-10- D-M88812, ICD-10-D-M88819, ICD-10-D-M88821, ICD-10-D-M88822, ICD-10-D-M88829, ICD-10-D-M88831, ICD-10-D-M88832, ICD-10-D-M88839, ICD-10-D-M88841, ICD-10-DM88849, ICD-10-D-M88851, ICD-10-D-M88852, ICD-10-D-M88859, ICD-10-D-M88861, ICD10-D-M88862, ICD-10-D-M88869, ICD-10-D-M88871, ICD-10-D-M88872, ICD-10-D-M8888, ICD-10-D-M8889, ICD-10-D-M889, ICD-10-D-M9060, ICD-10-D-M90621, ICD-10-DM90641, ICD-10-D-M90651, ICD-10-D-M90652, ICD-10-D-M90661, ICD-10-D-M90671, ICD10-D-M90672, ICD-10-D-M9068, ICD-10-D-M9069, ICD-9-D-5856, ICD-10-D-N186 |
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Agarwal, A., Tarawneh, O., Cohen, J. et al. The incremental risk of fragility fractures in aging men. Osteoporos Int 35, 495–503 (2024). https://doi.org/10.1007/s00198-023-06956-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-023-06956-8